JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2004; 43:1276-1282, doi:10.1016/j.jacc.2003.10.048
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amin, M. G.
Right arrow Articles by Sarnak, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amin, M. G.
Right arrow Articles by Sarnak, M. J.

CLINICAL RESEARCH: ANEMIA AND THE HEART

Hematocrit and left ventricular mass: the Framingham Heart study

Manish G. Amin, MD*, Hocine Tighiouart, MS*, Daniel E. Weiner, MD{dagger}, Paul C. Stark, PhD*, John L. Griffith, PhD*, Bonnie MacLeod, BS*, Deeb N. Salem, MD{ddagger} and Mark J. Sarnak, MD{dagger},*

* Division of Clinical Care Research, Department of Medicine, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA
{dagger} Division of Nephrology, Department of Medicine, New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA
{ddagger} Division of Cardiology, Department of Medicine, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts., USA

Manuscript received May 13, 2003; revised manuscript received October 17, 2003, accepted October 20, 2003.

* Reprint requests and correspondence: Dr. Mark J. Sarnak, Box 391, Tufts-New England Medical Center, 750 Washington Street, Boston, Massachusetts 02111, USA.
msarnak{at}tufts-nemc.org

OBJECTIVES: The goal of this study was to investigate the relationship between hematocrit (Hct) and left ventricular mass index (LVMI) and LV hypertrophy (LVH) in subjects without known hypertension or cardiovascular disease in the Framingham Heart study.

BACKGROUND: Anemia may be an independent risk factor for cardiovascular disease in the general population. One potential explanation for this finding could be an association between Hct with LVMI or LVH.

METHODS: Linear and logistic regression analyses were used to evaluate the association between Hct with LVMI and LVH. All analyses were stratified by gender and further according to menopausal status in women.

RESULTS: There were 1,376 men and 1,769 women who met the inclusion criteria. The mean Hct and LVMI were 46.5% and 41.9%, and 127.3 and 95.8 g/m, respectively, in men and women. After adjustment for confounders, each 3% lower Hct was associated with a 2.6 g/m higher mean LVMI in men, and a 1.8 g/m higher mean LVMI in postmenopausal women (p < 0.05). There was a significant quadratic relationship between Hct and LVMI in premenopausal women (p < 0.01). Subjects in the lowest quartile of Hct (compared with the rest of the sample) had an adjusted odds ratio of LVH of 2.0 (95% confidence interval [CI] 1.3 to 3.0) in men and 1.4 (95% CI 0.8 to 2.4) in postmenopausal women.

CONCLUSIONS: In a sample without known hypertension or cardiovascular disease, a lower Hct is associated with echocardiographically determined LVH in men and a small but significantly higher LVMI in men and postmenopausal women. The clinical importance of these findings remains unknown.

Abbreviations and Acronyms
  Hct = hematocrit
  IVST = interventricular septum thickness
  LV = left ventricle/ventricular
  LVD = left ventricular diameter
  LVDI = left ventricular diameter index
  LVH = left ventricular hypertrophy
  LVMI = left ventricular mass index
  PWT = left ventricular posterior wall thickness




This article has been cited by other articles:


Home page
Diabetes CareHome page
P. C.Y. Tong, A. P.S. Kong, W.-Y. So, M. H.L. Ng, X. Yang, M. C.Y. Ng, R. C.W. Ma, C.-S. Ho, C. W.K. Lam, C.-C. Chow, et al.
Hematocrit, independent of chronic kidney disease, predicts adverse cardiovascular outcomes in chinese patients with type 2 diabetes.
Diabetes Care, November 1, 2006; 29(11): 2439 - 2444.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
B. Y. Salazar-Vazquez, M. Intaglietta, M. Rodriguez-Moran, and F. Guerrero-Romero
Blood Pressure and Hematocrit in Diabetes and the Role of Endothelial Responses in the Variability of Blood Viscosity
Diabetes Care, July 1, 2006; 29(7): 1523 - 1528.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2004 by the American College of Cardiology Foundation.